Milestone Scientific, Inc.

As of May 16, 2025, the market trend has shifted to mildly bearish, supported by bearish signals from the weekly MACD, Bollinger Bands, and daily moving averages, despite some bullishness indicated by the monthly KST.

As of March 2022, the management team of Milestone Scientific, Inc. includes Ms. Leslie Bernhard (Independent Non-Executive Chairman), Mr. Leonard Osser (Director), Mr. Gian Trombetta (Director), Mr. Neal Goldman (Independent Director), and Mr. Michael McGeehan (Independent Director). They are responsible for the company's strategic direction and governance.

Milestone Scientific, Inc. develops computer-controlled injection technologies for the medical and dental sectors, operating as a micro-cap company with a market cap of approximately $67.91 million. As of March 2025, it reported net sales of $2 million and a net loss of $2 million.

As of Jun 18, Milestone Scientific, Inc. has a market capitalization of 67.91 million, with recent net sales of 8.60 million and a net loss of 5.27 million for the four quarters ending in March 2025. As of December 2024, shareholder's funds were 5.83 million, and total assets were 9.80 million.